Results 1 to 10 of about 629,663 (337)

Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking

open access: yesCells, 2023
The potential of oligonucleotide therapeutics is undeniable as more than 15 drugs have been approved to treat various diseases in the liver, central nervous system (CNS), and muscles.
Priyanka Mangla   +2 more
doaj   +1 more source

The legacy of mRNA engineering: A lineup of pioneers for the Nobel Prize

open access: yesMolecular Therapy: Nucleic Acids, 2022
mRNA is like Hermes, delivering the genetic code to cellular construction sites, so it has long been of interest, but only to a small group of scientists, and only demonstrating its remarkable efficacy in coronavirus disease 2019 (COVID-19) vaccines ...
Miroslaw Janowski, Anna Andrzejewska
doaj   +1 more source

The role of SAXS and molecular simulations in 3D structure elucidation of a DNA aptamer against lung cancer

open access: yesMolecular Therapy: Nucleic Acids, 2021
Aptamers are short, single-stranded DNA or RNA oligonucleotide molecules that function as synthetic analogs of antibodies and bind to a target molecule with high specificity.
Dmitry Morozov   +18 more
doaj   +1 more source

Modulating the expression of tumor suppressor genes using activating oligonucleotide technologies as a therapeutic approach in cancer

open access: yesMolecular Therapy: Nucleic Acids, 2023
Tumor suppressor genes (TSGs) are frequently downregulated in cancer, leading to dysregulation of the pathways that they control. The continuum model of tumor suppression suggests that even subtle changes in TSG expression, for example, driven by ...
Georgina L. Gregory, Ian M. Copple
doaj   +1 more source

RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy

open access: yesFrontiers in Pharmacology, 2021
RNA-based therapies have been promising method for treating all kinds of diseases, and four siRNA-based drugs and two mRNA-based drugs have been approved and are on the market now. However, none of them is applied for cancer treatment.
Nuannuan Li   +4 more
doaj   +1 more source

The Application of Microfluidic Technologies in Aptamer Selection

open access: yesFrontiers in Cell and Developmental Biology, 2021
Aptamers are sequences of single-strand oligonucleotides (DNA or RNA) with potential binding capability to specific target molecules, which are increasingly used as agents for analysis, diagnosis, and medical treatment.
Yang Liu   +14 more
doaj   +1 more source

Physico-chemical foundations underpinning microarray and next-generation sequencing experiments [PDF]

open access: yes, 2013
Hybridization of nucleic acids on solid surfaces is a key process involved in high-throughput technologies such as microarrays and, in some cases, next-generation sequencing (NGS).
A. Buhot   +70 more
core   +8 more sources

Development of a sensitive ELISA to quantify apolipoprotein CIII in nonhuman primate serum

open access: yesJournal of Lipid Research, 2011
Apolipoprotein CIII (apoCIII), a major constituent of triglyceride-rich lipoprotein, has been proposed as a key contributor to hypertriglyceridemia on the basis of its inhibitory effects on lipoprotein lipase.
Yuxin Wang   +4 more
doaj   +1 more source

Nucleic acid amphiphiles: Synthesis, properties, and applications

open access: yesMolecular Therapy: Nucleic Acids, 2023
Nucleic acid amphiphiles, referring to nucleic acids modified with large hydrophobic groups, have been widely used in programmable bioengineering. Since nucleic acids are intrinsically hydrophilic, the hydrophobic groups endow nucleic acid amphiphiles ...
Amu Gubu   +5 more
doaj   +1 more source

Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis

open access: yesMolecular Therapy: Nucleic Acids, 2013
Lung pathology in cystic fibrosis is linked to dehydration of the airways epithelial surface which in part results from inappropriately raised sodium reabsorption through the epithelial sodium channel (ENaC).
Kenneth L Clark   +23 more
doaj   +1 more source

Home - About - Disclaimer - Privacy